ISSN: 1859 - 2872
Cardiovascular disease and COVID-19 pandemic
Main Article Content
Keywords
Abstract
Summary
COVID-19 pandemic is a serious problem, which affects millions of people worldwide. SARS-CoV-2 invades the host cells via ACE2 receptors and causes acute respiratory syndrome. Patients with cardiovascular cormobidities such as diabetes, hypertension, obesity, heart failure have worse prognosis and high mortality. The role of angiotensin converter enzyme, angiontension receptor blockers and neprilysin inhibitors is very important and is actively discussed. The potential treatment drugs such as antiviral, antimalarial may have the adverse effects on cardiovascular systems which need to be considered before initiating treatment.
Keywords: COVID-19, cardiovascular disease, angiotensin coverter enzyme inhibitors, angiotension receptors blockers.
Article Details
References
2. Adao R (2020) Inside the heart of COVID-19. Cardiovasc Res 8(5817604).
3. Fried JA et al (2020) The Variety of Cardiovascular Presentations of COVID-19. Circulation 3(10): 047164.
4. Hongde H et al (2020) Coronavirus fulminant myocarditis treated with glucocorticoid and human immunoglobulin. European Heart Journal.
5. W Li et al (2003) Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus Nature. 426(6965): 450-454.
6. Lippi G, Lavie CJ, Sanchis-Gomar F Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis, Prog Cardiovasc Dis. 2020 Mar 10. pii: S0033-0620(20)30055-4. doi: 10.1016/j.pcad.2020.03.001.
7. Mehra, Mandeep R, Ruschitzka, Frank (2020) COVID-19 Illness and Heart Failure: A Missing Link?. JACC: Heart Failure 248.
8. DM Roden et al (2020) Considerations for Drug Interactions on QTc in Exploratory COVID-19 (Coronavirus Disease 2019) Treatment. Circulation. 8(10): 047521.
9. Sanders JM et al (2020) Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review. JAMA. 13(2764727).
10. Simonnet A et al (2020) High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation. Obesity 9(10): 22831.
11. Wu, Qi et al (2017) ltered Lipid Metabolism in Recovered SARS Patients Twelve Years after Infection. Scientific Reports 7(1): 9110.
12. Zhang Y et al (2020) Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19. N Engl J Med 382(17):e38.
13. Zheng, Ying-Ying et al (2020) COVID-19 and the cardiovascular system. Nature Reviews Cardiology 17: 259-260.
Article Sidebar
